Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - Share price - Overview

Stock Report

Regeneron Pharmaceuticals Inc REGN

Last Price
$423.97

Day Change
9.00|2.17%

As of 15/02/2019
19:23:02 EST | USD
Minimum 15 Minutes Delay.

Last Close414.97
Day Range415.72 - 424.39
Mkt Cap46.33Bil
52-Wk Range281.89 - 431.32
Yield %-
ISINUS75886F1075
Volume700,044
P/E19.91
P/S7.25
P/CF22.17

Share Price

Financials
201620172018
More ...
Income Statement
Revenue4,860.435,872.236,710.80
Operating Income1,330.742,079.592,534.40
Net Income895.521,198.512,444.40
Basic EPS8.5511.2722.65
Avg. Diluted Shares Outstanding116116115
Balance Sheet
Current Assets3,180.194,335.036,447.60
Non Current Assets3,793.284,429.265,286.90
Total Assets6,973.478,764.2911,734.50
Current Liabilities1,241.501,135.481,442.80
Total Liabilities---
Total Equity4,449.256,144.088,757.30
Cash Flow
Operating Cash Flow1,473.401,307.112,195.10
Capital Expenditure-511.94-272.63-383.10
Free Cash Flow961.461,034.491,812.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

7,400
Key Stats
More ...
Price/Earning TTM18.32
Price/Book5.18
Price/Sales TTM7.50
Rev Growth (3 year avg)17.81
EPS Growth (3 year avg)-
Operating Margin % TTM37.77
Net Margin % TTM36.42
ROE TTM32.81
Debt/Equity0.08
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.